Roivant Sciences Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	13.31	29.05	32.71	31.53	55.29	23.8
Revenue Growth (YoY)	-56.36%	-11.19%	3.75%	-42.97%	132.34%	-64.85%
Cost of Revenue	1.17	0.91	1.6	3.03	8.97	2.06
Gross Profit	12.14	28.14	31.11	28.5	46.32	21.74
Selling, General & Admin	599.31	591.41	416.13	383.45	775.03	259.88
Research & Development	628.11	550.41	466.36	551.81	622.93	832.76
Total Operating Expenses	1,227	1,142	882.49	935.26	1,398	1,093
Operating Income	-1,215	-1,003	4,497	-906.76	-1,352	-1,071
Interest Income	191.55	258.38	146.43	32.18	0.37	-
Interest Expense	-	-	-	-	-7.04	-
Other Non-Operating Income (Expense)	101.99	63.33	-75.6	-10.41	434.57	172.35
Total Non-Operating Income (Expense)	293.54	321.7	70.82	21.77	427.9	172.35
Pretax Income	-921.73	-681.59	4,568	-884.99	-923.75	-898.55
Provision for Income Taxes	84.3	48.17	21.5	4.08	0.37	1.69
Net Income	-809.24	-171.98	4,349	-1,009	-845.26	-809.23
Minority Interest in Earnings	-196.79	-184.75	-117.72	-106.43	-78.85	-91
Earnings From Discontinued Operations	-	373.19	-313.78	-224.68	-	-
Net Income to Common	-809.24	-171.98	4,349	-1,009	-845.26	-809.23
Shares Outstanding (Basic)	710	696	807	713	670	630
Shares Outstanding (Diluted)	710	696	807	713	670	630
Shares Change (YoY)	-1.38%	-13.73%	13.17%	6.43%	6.30%	-1.70%
EPS (Basic)	-1.14	-0.25	5.39	-1.42	-1.26	-1.28
EPS (Diluted)	-1.14	-0.25	5.39	-1.42	-1.26	-1.28
Free Cash Flow	-766.86	-844.05	-766.65	-856.08	-695.17	-557.94
Free Cash Flow Per Share	-	-	-	-1.20	-1.04	-0.89
Gross Margin	91.21%	96.86%	95.11%	90.38%	83.78%	91.36%
Operating Margin	-9130.53%	-3453.32%	13746.93%	-2875.87%	-2444.82%	-4500.52%
Profit Margin	-7558.42%	-2511.84%	13897.70%	-2819.77%	-1671.52%	-3783.29%
FCF Margin	-5761.50%	-2905.21%	-2343.56%	-2715.14%	-1257.40%	-2344.80%
EBITDA	-1,211	-989.22	4,519	-887.91	-1,346	-1,071
EBITDA Margin	-9099.46%	-3404.89%	13814.29%	-2816.07%	-2434.09%	-4500.52%
EBIT	-1,215	-1,003	4,497	-906.76	-1,352	-1,071
EBIT Margin	-9130.53%	-3453.32%	13746.93%	-2875.87%	-2444.82%	-4500.52%
Effective Tax Rate	-9.15%	-7.07%	0.47%	-0.46%	-0.04%	-0.19%

Updated Feb 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q